Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Epilepsy and cognitive impairments in Alzheimer disease.

Palop JJ, Mucke L.

Arch Neurol. 2009 Apr;66(4):435-40. doi: 10.1001/archneurol.2009.15. Epub 2009 Feb 9. Review.

2.

Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L.

Neuron. 2007 Sep 6;55(5):697-711.

3.

Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.

Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, Wu T, Hamto P, Devidze N, Yu GQ, Palop JJ, Noebels JL, Mucke L.

J Neurosci. 2011 Jan 12;31(2):700-11. doi: 10.1523/JNEUROSCI.4152-10.2011.

4.

Seizures in Alzheimer's disease.

Born HA.

Neuroscience. 2015 Feb 12;286:251-63. doi: 10.1016/j.neuroscience.2014.11.051. Epub 2014 Dec 4. Review.

PMID:
25484360
5.
7.

Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.

Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, Devidze N, Ho K, Yu GQ, Palop JJ, Mucke L.

Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):E2895-903. doi: 10.1073/pnas.1121081109. Epub 2012 Aug 6.

8.

Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.

Sanchez-Ramos J, Song S, Sava V, Catlow B, Lin X, Mori T, Cao C, Arendash GW.

Neuroscience. 2009 Sep 29;163(1):55-72. doi: 10.1016/j.neuroscience.2009.05.071. Epub 2009 Jun 14.

PMID:
19500657
9.

Role of Liver X Receptor in AD Pathophysiology.

Sandoval-Hernández AG, Buitrago L, Moreno H, Cardona-Gómez GP, Arboleda G.

PLoS One. 2015 Dec 31;10(12):e0145467. doi: 10.1371/journal.pone.0145467. eCollection 2015.

10.

Seizures and epileptiform activity in the early stages of Alzheimer disease.

Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, Hegde M, Cornes SB, Henry ML, Nelson AB, Seeley WW, Geschwind MD, Gorno-Tempini ML, Shih T, Kirsch HE, Garcia PA, Miller BL, Mucke L.

JAMA Neurol. 2013 Sep 1;70(9):1158-66. doi: 10.1001/jamaneurol.2013.136.

11.

Sodium channel cleavage is associated with aberrant neuronal activity and cognitive deficits in a mouse model of Alzheimer's disease.

Corbett BF, Leiser SC, Ling HP, Nagy R, Breysse N, Zhang X, Hazra A, Brown JT, Randall AD, Wood A, Pangalos MN, Reinhart PH, Chin J.

J Neurosci. 2013 Apr 17;33(16):7020-6. doi: 10.1523/JNEUROSCI.2325-12.2013. Erratum in: J Neurosci. 2013 Jun 26;33(26):10934. Brown, Jon T [added]; Randall, Andrew D [added].

12.

Alzheimer's disease and amyloid: culprit or coincidence?

Skaper SD.

Int Rev Neurobiol. 2012;102:277-316. doi: 10.1016/B978-0-12-386986-9.00011-9. Review.

PMID:
22748834
13.

Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.

García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.

J Alzheimers Dis. 2011;24(3):421-54. doi: 10.3233/JAD-2011-101635.

PMID:
21297257
14.

Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.

Caccamo A, Branca C, Talboom JS, Shaw DM, Turner D, Ma L, Messina A, Huang Z, Wu J, Oddo S.

J Neurosci. 2015 Oct 14;35(41):14042-56. doi: 10.1523/JNEUROSCI.2781-15.2015.

15.

Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin?

Palop JJ, Mucke L.

Neuromolecular Med. 2010 Mar;12(1):48-55. doi: 10.1007/s12017-009-8097-7. Epub 2009 Oct 17. Review.

16.

Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.

Stancu IC, Ris L, Vasconcelos B, Marinangeli C, Goeminne L, Laporte V, Haylani LE, Couturier J, Schakman O, Gailly P, Pierrot N, Kienlen-Campard P, Octave JN, Dewachter I.

FASEB J. 2014 Jun;28(6):2620-31. doi: 10.1096/fj.13-246702. Epub 2014 Mar 6.

17.

Memory retrieval by activating engram cells in mouse models of early Alzheimer's disease.

Roy DS, Arons A, Mitchell TI, Pignatelli M, Ryan TJ, Tonegawa S.

Nature. 2016 Mar 24;531(7595):508-12. doi: 10.1038/nature17172. Epub 2016 Mar 16.

18.

Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain.

Lleó A, Blesa R, Queralt R, Ezquerra M, Molinuevo JL, Peña-Casanova J, Rojo A, Oliva R.

Arch Neurol. 2002 Nov;59(11):1759-63.

PMID:
12433263
20.

Mouse models of Alzheimer's disease: the long and filamentous road.

Phinney AL, Horne P, Yang J, Janus C, Bergeron C, Westaway D.

Neurol Res. 2003 Sep;25(6):590-600. Review.

PMID:
14503012

Supplemental Content

Support Center